Mid-Term Results of Surgical Aortic Valve Replacement with Bioprostheses in Hemodialysis Patients

SSRN Electronic Journal(2022)

引用 0|浏览5
暂无评分
摘要
•HD patients underwent SAVR-BP for AS (hospital mortality, 8.8%; 5-year mortality, 42.1%).•Preoperative risk factors for 5-year mortality: age, hyperlipidemia, LVDd, LVDs, and Japan SCORE.•Postoperative risk factors for 5-year mortality: length of ICU stay, and albumin level at discharge.
更多
查看译文
关键词
Hemodialysis,Surgical aortic valve replacement,Bioprostheses,Aortic valve stenosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要